Condition of newborns in women of different age groups giving birth for the first time
DOI:
https://doi.org/10.15574/SP.2025.6(150).2933Keywords:
pregnancy, women giving birth for the first time, the age of the pregnant woman, the condition of newborns, the early neonatal period, complications, perinatal consequences of childbirthAbstract
Aim - to conduct a retrospective analysis of the condition of newborns in women of different age groups who are giving birth for the first time in order to determine the dependence of the frequency of perinatal complications on the age of the pregnant woman.Materials and methods. The perinatal consequences of childbirth were analyzed according to 154 birth histories of women giving birth for the first time, who were divided into groups according to age: the group I of the study 78 pregnant women aged 20-29 years, the group II - 76 pregnant women aged 30-40 years. Results. Іn the state of asphyxia, women giving birth for the first time in the group II (aged 30-40 years) had 4.3 times more newborns compared to women in the group I: in mild asphyxia 8 (10.5%) cases versus 3 (3.8%) cases; and moderate and severe asphyxia was observed only in women in the group II: 3 (3.9%) cases and 2 (2.6%) cases. Premature newborns in the group II were born significantly more - 9 (11.8%) cases versus 2 (2.6%) cases in the group I of the study; with fetal growth retardation syndrome (FGS) 11 (14.5%) cases versus 4 (5.1%) cases. In the group ІІ, posthypoxic encephalopathy and neonatal respiratory distress syndrome were diagnosed in 11 (14.5%) versus 3 (3.8%) cases in the group ІІ and 7 (9.2%) versus 1 (1.3%) cases, respectively. Conclusions. The increase in perinatal morbidity is directly correlated with the degree of perinatal risk in pregnant women giving birth for the first time at the age of 30 to 40 years, which is observed among such diseases of newborns as asphyxia, prematurity, fetal growth retardation syndrome, posthypoxic encephalopathy and respiratory distress syndrome
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the institution mentioned in the paper. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the author.
References
ACOG. (2020). Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin, Number 222. Obstetrics & Gynecology. 135(6): e237-e260. https://doi.org/10.1097/AOG.0000000000003891; PMid:32443079
Aneman I, Pienaar D, Šuvakov S, Simić T, Garovic V, McClements L. (2020). Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia. Frontiers in Immunology. 11 1864. https://doi.org/10.3389/fimmu.2020.01864; PMid:33013837 PMCid:PMC7462000
Artomenko VV, Dubossarska YuO, Zhylka NIa, Zhuk SI, Kaminskyi VV, Konkov DH, ta insh. (2022). Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy «Hipertenzyvni rozlady pid chas vahitnosti, polohiv ta u pisliapolohovomu periodi». Zdorov'ia Ukrainy. (1-2): 28-35.
Brownfoot F, Rolnik D. (2024). Prevention of preeclampsia. Best practice & research. Clinical obstetrics & gynaecology. 93: 102481. https://doi.org/10.1016/j.bpobgyn.2024.102481; PMid:38373378
Chang K, Seow K, Chen K. (2023). Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition. International Journal of Environmental Research and Public Health. 20(4): 2994. https://doi.org/10.3390/ijerph20042994; PMid:36833689 PMCid:PMC9962022
Derzhavna statystyka Ukrainy. (2024). Demohrafichna ta sotsialna statystyka. [Державна статистика України. (2024). Демографічна та соціальна статистика]. URL: https://www.ukrstat.gov.ua/operativ/oper_new.html.
Dines V, Šuvakov S, Kattah A, Vermunt J, Narang K, Jayachandran M et al. (2023). Preeclampsia and the Kidney: Pathophysiology and Clinical Implications. Comprehensive Physiology. 13(1): 4231-4267. https://doi.org/10.1002/j.2040-4603.2023.tb00249.x; PMid:36715282
D'Souza R, Kingdom J. (2016). Preeclampsia. Canadian Medical Association Journal. 188: 1178-1178. https://doi.org/10.1503/cmaj.151551; PMid:27573744 PMCid:PMC5088080
Gracia V, Vargas C, Sánchez J, Collantes-Cubas J. (2023). Preeclampsia: Narrative review for clinical use. Heliyon. 9(3): e14187. https://doi.org/10.1016/j.heliyon.2023.e14187; PMid:36923871 PMCid:PMC10009735
Gumusoglu S, Chilukuri A, Santillan D, Santillan M. Stevens H. (2020). Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure. Trends in Neurosciences. 43: 253-268. https://doi.org/10.1016/j.tins.2020.02.003; PMid:32209456 PMCid:PMC7170230
Han C, Chen Y, Dong J. (2021). Prothrombotic state associated with preeclampsia. Current Opinion in Hematology. 28: 323-330. https://doi.org/10.1097/MOH.0000000000000678; PMid:34267080 PMCid:PMC8373789
MacDonald T, Walker S, Hannan N, Tong S, Kaitu'u-Lino T. (2021). Clinical tools and biomarkers to predict preeclampsia. EBioMedicine. 75: 103780. Epub 2021 Dec 23. https://doi.org/10.1016/j.ebiom.2021.103780; PMid:34954654 PMCid:PMC8718967
Masini G, Foo L, Tay J, Wilkinson I, Valensise H et al. (2021). Preeclampsia has two phenotypes which require different treatment strategies. American journal of obstetrics and gynecology. 226(2S): S1006-S1018. Epub 2021 Jun 10. https://doi.org/10.1016/j.ajog.2020.10.052; PMid:34774281
Miller D, Motomura K, Galaz J, Gershater M, Lee E et al. (2021). Cellular immune responses in the pathophysiology of preeclampsia. Journal of Leukocyte Biology. 111: 237-260. https://doi.org/10.1002/JLB.5RU1120-787RR; PMid:33847419 PMCid:PMC8511357
Mintser AP. (2018). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 3: 41-45.
Nirupama R, Divyashree S, Janhavi P, Muthukumar S, Ravindra P. (2020). Preeclampsia: Pathophysiology and Management. Journal of gynecology obstetrics and human reproduction. 50(2): 101975. Epub 2020 Nov 7. https://doi.org/10.1016/j.jogoh.2020.101975; PMid:33171282
Opichka M, Rappelt M, Gutterman D, Grobe J, Mcintosh J. (2021). Vascular Dysfunction in Preeclampsia. Cells. 10(11): 3055. https://doi.org/10.3390/cells10113055; PMid:34831277 PMCid:PMC8616535
Overton E, Tobes D, Lee A. (2022). Preeclampsia diagnosis and management. Best practice & research. Clinical anaesthesiology. 36(1): 107-121. https://doi.org/10.1016/j.bpa.2022.02.003; PMid:35659948
Roberts J. (2024). Preeclampsia epidemiology(ies) and pathophysiology(ies). Best practice & research. Clinical obstetrics & gynaecology. 94: 102480. https://doi.org/10.1016/j.bpobgyn.2024.102480; PMid:38490067
Roberts J, Rich-Edwards J, McElrath T, Garmire L, Myatt L. (2021). Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness. Hypertension. 77: 1430-1441. https://doi.org/10.1161/HYPERTENSIONAHA.120.14781; PMid:33775113 PMCid:PMC8103569
Spichak KO, Govsieiev DO. (2023). An analysis of perinatal outcomes in pregnant women with arterial hypertension in Poland and Ukraine during times of conflict. Ukrainian Journal of Perinatology and Pediatrics, 2(94): 70-76. https://doi.org/10.15574/PP.2023.94.70
Tsentr medychnoi statystyky MOZ Ukrainy. (2025). Statystychni dani 2022-2024 r. URL: http://medstat.gov.ua
Wan Y, Arvizu M, Rich-Edwards J, Wang L, Rosner B, Stuart J et al. (2021). Hypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality. Journal of the American College of Cardiology. 77(10): 1302-1312. https://doi.org/10.1016/j.jacc.2021.01.018; PMid:33706872 PMCid:PMC7959184
Wang Y, Li B, Zhao Y. (2022). Inflammation in Preeclampsia: Genetic Biomarkers, Mechanisms, and Therapeutic Strategies. Frontiers in Immunology. 13: 883404. https://doi.org/10.3389/fimmu.2022.883404; PMid:35880174 PMCid:PMC9307876
Wu P, Green M, Myers J. (2023). Hypertensive disorders of pregnancy. BMJ. 381: e071653. https://doi.org/10.1136/bmj-2022-071653; PMid:37391211
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
